Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Corvidia
company
About
Corvidia Therapeutics focuses on the research and development of transformative therapies for cardio-renal diseases.
- Waltham,Massachusetts,United States
- 11 - 50
- http://corvidiatx.com/
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $26M
- Industries
- Biotechnology,Genetics,Health Care,Medical,Therapeutics
- Founded date
- Jan 1, 2014
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Legal Name
- Corvidia Therapeutics, Inc.
- Also Known As
- Corvidia Therapeutics
Corvidia Therapeutics is a clinical stage company focused on the research, development, and commercialization of transformative therapies for cardio-renal diseases. The Company is currently developing potential treatments for chronic kidney disease with atherosclerotic cardiovascular disease and inflammation, and high triglyceride-induced acute pancreatitis.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$86.82M
Corvidia has raised a total of
$86.82M
in funding over 2 rounds. Their latest funding was raised on
Mar 24, 2020 from a Convertable Note round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 24, 2020 | Convertable Note | $827.33K | 1 | — | — | Detail |
| Apr 25, 2018 | Series B | $60M | 9 |
Venrock
|
— | Detail |
| Feb 17, 2016 | Series A | $26M | 2 |
Apple Tree Partners
Sofinnova Partners
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
3
9
Corvidia is funded by 9 investors.
Venrock
and HBM Healthcare Investments AG
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Venrock
|
Yes | Series B |
HBM Healthcare Investments AG
|
— | Convertable Note |
|
|
— | Series B |
|
Apple Tree Partners
|
— | Series B |
Cormorant Asset Management
|
— | Series B |
Fresenius Medical Care
|
— | Series B |
MedImmune
|
— | Series B |
|
Sofinnova Partners
|
— | Series B |
|
|
— | Series B |
Employee Profiles
Number of Employee Profiles
4
Corvidia has 4 current employee profiles, including
Board member Seth Harrison
Board member
Board member
Board member
Board member
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
